Substitution of brand name drugs

Sec. 2. Subject to IC 16-42-22: (1) a pharmacist shall not substitute; and (2) a health maintenance organization shall not require the substitution of; a different single source brand name drug for a single source brand name drug written on a prescription form or electronically transmitted to a pharmacy unless the substitution is approved by the prescribing provider. As added by P.L.69-1998, SEC.16. Amended by P.L.204-2005, SEC.20.